INVICTUS MD STRATEGIES CORP.’s (TSXV: IMH; OTC: IVITF; FRA: 8IS1) Acreage Pharms Ltd. is pleased to announce that it has received notification from Health Canada (HC) that its sales license inspection has been scheduled for later in March and is anticipated to take up to three days. The Sales License Inspection is the last step prior to the issuance of a Sales License under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR“).
“As there are currently only 40 cannabis sales licenses under the ACMPR in Canada, receiving confirmation of our Sales License Inspection from Health Canada is a major milestone for Acreage Pharms. I’m extremely proud of our CEO at Acreage Pharms, Trevor Dixon and our cultivation team. Their dedication shows in the high-quality flower being produced at Acreage Pharms. Our team’s ability to execute has allowed us to advance to the Pre-Sales License Inspection for which I am delighted,” said Dan Kriznic, Chairman and CEO of Invictus.
Currently Acreage Pharms has a total of 191 kilograms of dried marijuana in their vault. Invictus’ AB Laboratories Inc. (“AB Labs“) received its amendment to sell dried marijuana under the ACMPR in January 2018.
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on two main verticals within the Canadian cannabis sector, namely the Licensed Producers under the ACMPR, being its 100% investment in Acreage Pharms Ltd., located in West-Central Alberta, and 50% investment in AB Laboratories Inc., located near Hamilton, Ontario which has both its cultivation and sales license under ACMPR. In addition to ACMPR licenses, the Company has an 82.5% investment in Future Harvest Development Ltd. a Fertilizer and Nutrients manufacturer based in Kelowna, British Columbia.
In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.
